Summary
Remoxipride is a recently developed benzamide derivative with well established antipsychotic efficacy. Several other antipsychotic compounds have been shown to induce alterations in water and electrolyte balance due to an effect on the secretion of antidiuretic hormone (ADH). 11 healthy male volunteers (mean age 33 years) participated in a double blind, placebo controlled, crossover study to investigate whether remoxipride interacts with the secretion of ADH following fluid restriction.
The subjects received 100mg remoxipride or placebo as single oral doses. No differences were observed between the two treatments with regard to effect on ADH secretion, urine volume, serum or urinary concentrations of electrolytes, creatinine or osmolality. In conclusion, remoxipride in a single oral dose of 100mg has no influence on the secretion of ADH or ADH regulated concentration mechanisms in healthy volunteers.
Similar content being viewed by others
References
Adam WR. Aldosterone and dopamine receptors in the kidney: sites for pharmacological manipulations of renal function. Kidney International 18: 623–635, 1980
Ajlouni K, Kenn MW, Tunes JF. Thiothixene induced hyponatremia. Archives of Internal Medicine 134: 1103–1105, 1974
Barlow ED, de Wardener HE. Compulsive water drinking. Quarterly Journal of Medicine 235: 58, 1959
Courtney N, Raskind M. Vasopressin affects adenylate cyclase activity in rat brain: a possible neuromodulator. Life Sciences 32: 591–596, 1983
Derivera JI. Inappropriate secretion of antidiuretic hormone from fluphenazine therapy. Annals of Internal Medicine 82: 811, 1975
Dourish CT. Dopaminergic involvement in the control of drinking behaviour: a brief review. Progress in Neuropsychopharmacology and Biological Psychiatry 7: 487–493, 1983
Editorial. Remoxipride. Drugs of the Future 11: 944–948, 1986
Forrest Jr JN, Singer I. Drug-induced interference with action of antidiuretic hormone. In Andreoli et al. (Eds) pp. 309–340, Disturbances in body fluid osmolality. Williams and Wilkins Co, Baltimore, 1977
Frederickson ED, Bradley T, Goldberg LI. Blockade of renal effects of dopamine in the dog by the DA. antagonist SCH23390. American Journal of Physiology 249: F236–240, 1985
Grind M, Nilsson MI, Nilsson L, Oxenstierna G, Sedvall G, et al. Remoxipride - a new potential antipsychotic compound: tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers. Psychopharmacology 98: 304–309, 1989
Hall H, Sällemark M, Jerning E. Effects of remoxipride and some related new substituted salicylamines on rat brain receptors. Pharmacology and Toxicology 58: 61–70, 1986
Hays RM. Antidiuretic hormone. NEJM 295: 659–665, 1976
Hegde SS, Ricci AS, Amenta F, Lokhandwala MF. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. Journal of Pharmacology and Experimental Therapeutics 251: 1237–1245, 1989
Hoskins RG, Sleeper FH. Organic functions of schizophrenia. Archives of Neurology and Psychiatry 30: 123–140, 1933
Janison RL, Mamy RH. The urinary concentrating mechanism. New England Journal of Medicine 295: 1059–1066, 1976
Kosten TR, Camp W. Inappropriate secretion of antidiuretic hormone in a patient receiving piperazine phenothiazines. Psychosomatics 21: 351–355, 1980
Lewander T, Westerbergh SE, Morrison D. Clinical profile of remoxipride - a combined analysis of a comparative double-blind multicenter trial programme. Acta Psychiatrica Scandinavica 82(Suppl. 358): 92–98, 1990
Lightman SL, Forsling M. Evidence for dopamine as an inhibitor of vasopressin release in man. Clinical Endocrinology 12: 39–46, 1980
Lightman SL, Iversen LL, Forsling ML. Dopamine and (D-Ala2-D-Leu5) enkephalin inhibit the electrically stimulated neurohypophyseal release of vasopressin in vitro: evidence for calcium-dependent opiate action. J Neurosci 2: 78–8l, 1982
Morrison D, Englund A, Lawrie V, Lewander T, Schlachet A, et al. Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipride. Acta Psychiatrica Scandinavica 82(Suppl. 358): 164–169, 1990
Nilsson LB. Determination of remoxipride in plasma and urine by reversed-phase column liquid chromatography. Journal of Chromatography 526: 139–150, 1990
Ögren SO, Hall H, Köhler C, et al. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actiom in the rat brain. Eur J Pharmacol 102: 459–474, 1984
Os I, Kjeldsen SE, Akesson I, Skj öt ö J, Eide I, et al. Evidence of age-related variation in plasma vasopressin of normotensive men. Scandinavian Journal of Clinical and Laboratory Investigation 45: 263–268, 1985
Pelayo JC, Fildes RD, Eisner GM, Jose PA. Effects of dopamine blockade on renal sodium excretion. American Journal of Psychology 245: F245–253. 1983
Racké K, Meuresch J, Trapp B, McScholl E. Modulation by feldopamin (SKF 82526) and bromocriptine of the electrically evoked release of vasopressin from the rat neurohypophysis. Naunyn-Schmiedeberg’s Arch Pharmacol 332: 332–337, 1986
Racké K, Rothländer M, Trapp B. Effects of the dopaminergic drug SKF 82526 and of forskolin on the electrically evoked vasopressin release from the isolated neurointermediate lobe. Naunyn-Schmiedeberg’s Arch Pharmacol 319: R74, 1982
Rajerison R, Marchetti C, Roy J, Bochaert J, Jard S. The vasopressin-sensitive adenylate cyclase of the rat kidney. Journal of Biological Chemistry 249: 6390–6400, 1974
Raskind MA, Courtney N, Murburg MM. et al. Antipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients. Biological Psychiatry 22: 453–462, 1987
Shen WW, Sata LS. Self-induced water intoxication and hyperdopaminergic state. Am J Psychiatry 141: 1305–1306, 1984
Sing S, Padi MH, Bullard H, Freeman H. Water intoxication in psychiatric patients. Brit J Psychiatry 146: 127–131, 1985
Tildesley HD, Toth E, Croford PM. Syndrome of inappropriate secretion of antidiuretic hormone in association with chlorpromazine ingestion. Can J Psychiatry 28: 487–488, 1983
Zerbe LR, Robertsson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. NEJM 305: 1539–1546, 1981
Zubenko GS. Water homeostasis in psychotic patients. Biological Psychiatry 22: 121–125, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Widerlöv, E., Odlind, B., Delin, K. et al. Lack of Effect of Remoxipride on Antidiuretic Hormone Secretion in Healthy Volunteers. Drug Invest 3, 19–24 (1991). https://doi.org/10.1007/BF03259536
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259536